Inventor · disambiguated record
Joel Mcintosh
Also filed as: MCINTOSH JOEL
14 granted patents·7 pending applications·174 citations·filing 2007–2023
93Inventor score
Top patents by PatentIndex Score
21 records- 0194US11866442B2Bifunctional compounds for degrading BTK via ubiquitin proteosome pathwayNURIX THERAPEUTICS INC·Filed 2022·Granted Jan 9, 2024·5 cites·37 claims
- 0294US7902194B2Inhibitors of bruton's tyrosine kinaseRoche Palo Alto·Filed 2009·Granted Mar 8, 2011·33 cites·7 claims
- 0393US11479556B1Bifunctional compounds for degrading BTK via ubiquitin proteosome pathwayNURIX THERAPEUTICS INC·Filed 2019·Granted Oct 25, 2022·9 cites·106 claims
- 0493US7906509B2Inhibitors of bruton's tyrosine kinaseROCHE PALO ALTO LLC·Filed 2009·Granted Mar 15, 2011·26 cites·21 claims
- 0592US8124604B2Inhibitors of bruton's tyrosine kinaseDEWDNEY NOLAN JAMES·Filed 2011·Granted Feb 28, 2012·22 cites·23 claims
- 0691US7683064B2Inhibitors of Bruton's tyrosine kinaseROCHE PALO ALTO LLC·Filed 2009·Granted Mar 23, 2010·22 cites·19 claims
- 0789US10214522B2Anti-alphavbeta1 integrin inhibitors and methods of useUNIV CALIFORNIA·Filed 2016·Granted Feb 26, 2019·15 cites·19 claims
- 0888US9593129B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2016·Granted Mar 14, 2017·5 cites·18 claims
- 0988US9296736B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2014·Granted Mar 29, 2016·7 cites·13 claims
- 1087US2024300892A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2023·Application pending·0 cites
- 1186US9376425B2Heterocyclic compounds as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2012·Granted Jun 28, 2016·12 cites·37 claims
- 1284US7645764B2Kinase inhibitors and methods for using the sameROCHE PALO ALTO LLC·Filed 2007·Granted Jan 12, 2010·8 cites·16 claims
- 1382US8822457B2Inhibitors of bruton's tyrosine kinaseROCHE PALO ALTO LLC·Filed 2013·Granted Sep 2, 2014·4 cites·6 claims
- 1480US8618098B2Inhibitors of bruton's tyrosine kinaseDEWDNEY NOLAN JAMES·Filed 2012·Granted Dec 31, 2013·4 cites·6 claims
- 1577US10836720B2Inhibitors of integrin alpha 5 beta 1 and methods of useUNIV CALIFORNIA·Filed 2017·Granted Nov 17, 2020·2 cites·21 claims
- 1674US2021179560A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2020·Application pending·0 cites
- 1767US2019062276A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2018·Application pending·0 cites
- 1865US2014011796A1Piperidinone derivatives as mdm2 inhibitors for the treatment of cancerAMGEN INC·Filed 2013·Application pending·0 cites
- 1964US2017144971A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2017·Application pending·0 cites
- 2058US2023158151A1Compounds for inhibiting or degrading target proteins, compositions, comprising the same, methods of their making, and methods of their useNURIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2157US2024279202A1Compounds for inhibiting or degrading itk, compositions, comprising the same methods of their making and methods of their useNURIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joel Mcintosh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →